Lymelyte is a modern hybrid cannabis strain produced by crossing Mendo Breath F2 and Banana Kush. Its history and exact origins remain undocumented, as there is currently no formal record detailing the specific breeder or the circumstances surrounding its initial development. This strain maintains a stable genetic identity derived from its well-known parents, though its precise timeline of emergence is not tracked in current cultivation databases.

The terpene profile of Lymelyte is dominated by limonene, followed by myrcene, caryophyllene, nerolidol, linalool, beta-pinene, pinene, humulene, caryophyllene-oxide, guaiol, bisabolol, camphene, p-cymene, terpinolene, geraniol, ocimene, alpha-terpinene, and gamma-terpinene. This complex arrangement of compounds dictates the strain’s sensory experience, which tends to highlight a distinct citrus-forward aromatic profile supported by earthy and floral undertones. Growers can expect a moderate level of difficulty when cultivating Lymelyte, which thrives in both indoor and outdoor environments and reaches maturity after a 63-day flowering period, consistently producing a high yield.

As a THC-dominant variety, Lymelyte is frequently utilized by patients seeking relief from stress and pain, and it is often pursued for its assistance in promoting sleep. Users typically report feelings of relaxation, happiness, and an uplifted state of mind following consumption. Lymelyte currently has no recorded offspring, serving as a distinct end-point in its current genetic line.